Skip to main content

Table 2 Patients’ data of prothesis

From: Treatment and outcome of malignant bone tumors of the proximal humerus: biological versus endoprosthetic reconstruction

Case

Age (year)/gender

Ennecking’s stage

Specimen length (cm)

Local recurrence (months)

Pulmonary metastasis (months)

Revisions (number, months)

MSTS score (%)

Follow-up time (months)

1

29/M

Stage IIB

8.0

No

No

Aspetic loosening (1,68)

66

Alive, 120

2

37/M

Stage IIA

9.5

No

No

Aspetic loosening (1,89)

73

Alive, 112

3

26/F

Stage IIB

12.5

No

No

Aspetic loosening (1,76)

67

Alive, 105

4

18/M

Stage IIB

13.0

No

Conservative (20)

---

65

Death, 27

5

24/M

Stage IIB

13.5

No

No

---

65

Death, 76

6

41/F

Stage IIA

10.3

No

No

Aspetic loosening (1,73)

71

Alive, 82

7

36/M

Stage IIA

11.5

Amputation (16)

No

---

56

Death, 41

8

20/M

Stage IIB

12.5

No

No

Aspetic loosening (1,66)

67

Alive, 75

9

32/M

Stage IIB

12.8

No

Conservative (25)

---

60

Death, 34

10

28/F

Stage IIA

10.5

No

No

Aspetic loosening (1,61)

62

Death, 69

11

31/F

Stage IIB

8.5

No

No

---

67

Alive, 60

12

25/F

Stage IIB

10.5

No

No

Aspetic loosening (1,50)

61

Alive, 57

13

38/M

Stage IIB

10.0

Amputation (23)

No

---

51

Alive, 55

14

26/F

Stage IIA

9.5

No

No

---

58

Alive, 50

15

32/F

Stage IIA

11.0

No

No

---

63

Alive, 48

16

27/F

Stage IIB

9.5

No

Conservative (19)

---

72

Death, 26

17

31/M

Stage IIB

12.5

No

No

Aspetic loosening (1,43)

63

Alive, 47

18

38/M

Stage IIA

11.0

No

No

---

64

Alive, 45

19

29/F

Stage IIA

11.5

No

No

---

56

Alive, 41

20

31/F

Stage IIA

9.5

No

Conservative (32)

---

67

Death, 35

21

23/M

Stage IIB

10.2

No

No

Aspetic loosening (1,31)

62

Alive, 39

22

39/M

Stage IIB

11.3

No

No

---

67

Alive, 36

23

27/F

Stage IIB

10.0

Amputation (19)

No

---

53

Death, 32

24

25/M

Stage IIA

12.5

No

No

---

70

Alive, 35

25

28/F

Stage IIA

13.0

No

No

---

64

Alive, 30